Emphysematous changes are caused by degradation of type III collagen in transgenic mice expressing MMP-1

Takayuki Shiomi, Yasunori Okada, Robert Foronjy, John Schiltz, Rudolph Jaenish, Steve Krane, Jeanine D'Armiento

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Disruption of the extracellular matrix is believed to play an important role in the pathogenesis of emphysema. Prior studies have demonstrated that transgenic mice expressing the human tissue collagenase, matrix metalloproteinase 1 (MMP-1), develop emphysema. MMP-1 is a protease with substrate specificity for fibrillar collagen. Type I and III collagens, which are the most abundant proteins within the lungs, are the primary substrates for MMP-1. To assess if type I collagen was indeed the site of action for MMP-1 in these transgenic mice, hybrid mice were generated by crossing the MMP-1 transgenic mice with mice that had degradation-resistant type I collagen. The hybrid mice demonstrated an identical emphysematous phenotype as the MMP-1 transgenic mice, indicating that the degradation of type I collagen was not essential to the development of emphysema in these mice. Immunohistochemical studies in control mice demonstrated that collagen fibers in the alveolar walls and ducts of the normal mouse lungs consist mainly of type III collagen. In the transgenic and hybrid mice, the emphysematous changes, which developed, were associated with a marked decrease in type III collagen in these alveolar structures. These results indicate that MMP-1 generated the emphysematous phenotype via the degradative effect on type III collagen, which is a vital structural element of the alveolar walls. This is the first study to show that a matrix metalloproteinase may cause emphysema via its effects on a specific collagen subtype. As such, it should provide important insight into the mechanisms of this disease in humans.

Original languageEnglish
Pages (from-to)1-15
Number of pages15
JournalExperimental Lung Research
Volume29
Issue number1
DOIs
Publication statusPublished - 2003 Jan

Fingerprint

Matrix Metalloproteinase 1
Collagen Type III
Transgenic Mice
Degradation
Emphysema
Collagen Type I
Collagen
Fibrillar Collagens
Phenotype
Lung
Collagenases
Substrates
Substrate Specificity
Matrix Metalloproteinases
Ducts
Extracellular Matrix
Peptide Hydrolases
Tissue
Fibers

Keywords

  • Collagen
  • Collagenase
  • Emphysema
  • Transgenic mice

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Shiomi, T., Okada, Y., Foronjy, R., Schiltz, J., Jaenish, R., Krane, S., & D'Armiento, J. (2003). Emphysematous changes are caused by degradation of type III collagen in transgenic mice expressing MMP-1. Experimental Lung Research, 29(1), 1-15. https://doi.org/10.1080/01902140303761

Emphysematous changes are caused by degradation of type III collagen in transgenic mice expressing MMP-1. / Shiomi, Takayuki; Okada, Yasunori; Foronjy, Robert; Schiltz, John; Jaenish, Rudolph; Krane, Steve; D'Armiento, Jeanine.

In: Experimental Lung Research, Vol. 29, No. 1, 01.2003, p. 1-15.

Research output: Contribution to journalArticle

Shiomi, T, Okada, Y, Foronjy, R, Schiltz, J, Jaenish, R, Krane, S & D'Armiento, J 2003, 'Emphysematous changes are caused by degradation of type III collagen in transgenic mice expressing MMP-1', Experimental Lung Research, vol. 29, no. 1, pp. 1-15. https://doi.org/10.1080/01902140303761
Shiomi, Takayuki ; Okada, Yasunori ; Foronjy, Robert ; Schiltz, John ; Jaenish, Rudolph ; Krane, Steve ; D'Armiento, Jeanine. / Emphysematous changes are caused by degradation of type III collagen in transgenic mice expressing MMP-1. In: Experimental Lung Research. 2003 ; Vol. 29, No. 1. pp. 1-15.
@article{728be944959642bc90e5e9fcd3940081,
title = "Emphysematous changes are caused by degradation of type III collagen in transgenic mice expressing MMP-1",
abstract = "Disruption of the extracellular matrix is believed to play an important role in the pathogenesis of emphysema. Prior studies have demonstrated that transgenic mice expressing the human tissue collagenase, matrix metalloproteinase 1 (MMP-1), develop emphysema. MMP-1 is a protease with substrate specificity for fibrillar collagen. Type I and III collagens, which are the most abundant proteins within the lungs, are the primary substrates for MMP-1. To assess if type I collagen was indeed the site of action for MMP-1 in these transgenic mice, hybrid mice were generated by crossing the MMP-1 transgenic mice with mice that had degradation-resistant type I collagen. The hybrid mice demonstrated an identical emphysematous phenotype as the MMP-1 transgenic mice, indicating that the degradation of type I collagen was not essential to the development of emphysema in these mice. Immunohistochemical studies in control mice demonstrated that collagen fibers in the alveolar walls and ducts of the normal mouse lungs consist mainly of type III collagen. In the transgenic and hybrid mice, the emphysematous changes, which developed, were associated with a marked decrease in type III collagen in these alveolar structures. These results indicate that MMP-1 generated the emphysematous phenotype via the degradative effect on type III collagen, which is a vital structural element of the alveolar walls. This is the first study to show that a matrix metalloproteinase may cause emphysema via its effects on a specific collagen subtype. As such, it should provide important insight into the mechanisms of this disease in humans.",
keywords = "Collagen, Collagenase, Emphysema, Transgenic mice",
author = "Takayuki Shiomi and Yasunori Okada and Robert Foronjy and John Schiltz and Rudolph Jaenish and Steve Krane and Jeanine D'Armiento",
year = "2003",
month = "1",
doi = "10.1080/01902140303761",
language = "English",
volume = "29",
pages = "1--15",
journal = "Experimental Lung Research",
issn = "0190-2148",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Emphysematous changes are caused by degradation of type III collagen in transgenic mice expressing MMP-1

AU - Shiomi, Takayuki

AU - Okada, Yasunori

AU - Foronjy, Robert

AU - Schiltz, John

AU - Jaenish, Rudolph

AU - Krane, Steve

AU - D'Armiento, Jeanine

PY - 2003/1

Y1 - 2003/1

N2 - Disruption of the extracellular matrix is believed to play an important role in the pathogenesis of emphysema. Prior studies have demonstrated that transgenic mice expressing the human tissue collagenase, matrix metalloproteinase 1 (MMP-1), develop emphysema. MMP-1 is a protease with substrate specificity for fibrillar collagen. Type I and III collagens, which are the most abundant proteins within the lungs, are the primary substrates for MMP-1. To assess if type I collagen was indeed the site of action for MMP-1 in these transgenic mice, hybrid mice were generated by crossing the MMP-1 transgenic mice with mice that had degradation-resistant type I collagen. The hybrid mice demonstrated an identical emphysematous phenotype as the MMP-1 transgenic mice, indicating that the degradation of type I collagen was not essential to the development of emphysema in these mice. Immunohistochemical studies in control mice demonstrated that collagen fibers in the alveolar walls and ducts of the normal mouse lungs consist mainly of type III collagen. In the transgenic and hybrid mice, the emphysematous changes, which developed, were associated with a marked decrease in type III collagen in these alveolar structures. These results indicate that MMP-1 generated the emphysematous phenotype via the degradative effect on type III collagen, which is a vital structural element of the alveolar walls. This is the first study to show that a matrix metalloproteinase may cause emphysema via its effects on a specific collagen subtype. As such, it should provide important insight into the mechanisms of this disease in humans.

AB - Disruption of the extracellular matrix is believed to play an important role in the pathogenesis of emphysema. Prior studies have demonstrated that transgenic mice expressing the human tissue collagenase, matrix metalloproteinase 1 (MMP-1), develop emphysema. MMP-1 is a protease with substrate specificity for fibrillar collagen. Type I and III collagens, which are the most abundant proteins within the lungs, are the primary substrates for MMP-1. To assess if type I collagen was indeed the site of action for MMP-1 in these transgenic mice, hybrid mice were generated by crossing the MMP-1 transgenic mice with mice that had degradation-resistant type I collagen. The hybrid mice demonstrated an identical emphysematous phenotype as the MMP-1 transgenic mice, indicating that the degradation of type I collagen was not essential to the development of emphysema in these mice. Immunohistochemical studies in control mice demonstrated that collagen fibers in the alveolar walls and ducts of the normal mouse lungs consist mainly of type III collagen. In the transgenic and hybrid mice, the emphysematous changes, which developed, were associated with a marked decrease in type III collagen in these alveolar structures. These results indicate that MMP-1 generated the emphysematous phenotype via the degradative effect on type III collagen, which is a vital structural element of the alveolar walls. This is the first study to show that a matrix metalloproteinase may cause emphysema via its effects on a specific collagen subtype. As such, it should provide important insight into the mechanisms of this disease in humans.

KW - Collagen

KW - Collagenase

KW - Emphysema

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0037216547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037216547&partnerID=8YFLogxK

U2 - 10.1080/01902140303761

DO - 10.1080/01902140303761

M3 - Article

VL - 29

SP - 1

EP - 15

JO - Experimental Lung Research

JF - Experimental Lung Research

SN - 0190-2148

IS - 1

ER -